Science Explorer Back to mapMap
Discussion
Topic · Pulmonary and Respiratory Medicine

Prostate Cancer Treatment and Research

Prostate Cancer Treatment and Research is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 49k research works in it since 1950. 10.4% of them reached the world's top 10% most cited for their field and year.

This cluster of papers represents a comprehensive exploration of advancements in prostate cancer research, covering topics such as androgen receptor signaling, genomic profiling, hormone therapy, immunotherapy, genetic mutations, clinical trials, biomarkers, and molecular biology. The papers discuss the molecular determinants of resistance to antiandrogen therapy, the impact of translocations and gene fusions on cancer causation, and the development of second-generation antiandrogens for the treatment of advanced prostate cancer.

  • Prostate Cancer
  • Androgen Receptor
  • Genomic Profiling
  • Hormone Therapy
  • Metastatic Prostate Cancer
  • Immunotherapy
  • Genetic Mutations
  • Clinical Trials
  • Biomarkers
  • Molecular Biology
Research works
49k
fractional, since 1950
In the world top 10%
5.1k
per year above
Top-10% rate
10.4%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+1%
the tick is no change
Largest producer
United States
41% of the 10 largest, 2022-now
Prostate Cancer Treatment and Research

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Prostate Cancer Treatment and Research research?

By volume, the United States and China publish the most (3.1k and 1.3k works in 2022-now).

By volume, 2022-now

  1. 1 United States 3.1k works
  2. 2 China 1.3k works
  3. 3 Germany 558 works
  4. 4 Italy 460 works
  5. 5 Japan 455 works
  6. 6 United Kingdom 411 works
  7. 7 Canada 340 works
  8. 8 France 292 works
  9. 9 India 274 works
  10. 10 Spain 260 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 41.5%China: 17.8%Germany: 7.5%Italy: 6.1%6 others listed: 27.1%41%largest
United States3,104 · 41.5%China1,334 · 17.8%Germany558 · 7.5%Italy460 · 6.1%6 others listed2,032 · 27.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Prostate Cancer Treatment and Research research?

By volume in 2022-now, Harvard University publishes the most Prostate Cancer Treatment and Research research, followed by Cornell University and National Institutes of Health.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 152 works
  2. 2 Cornell UniversityUnited States 74 works
  3. 3 National Institutes of HealthUnited States 71 works
  4. 4 Memorial Sloan Kettering Cancer CenterUnited States 68 works
  5. 5 Johns Hopkins UniversityUnited States 68 works
  6. 6 Mayo ClinicUnited States 65 works
  7. 7 University of TorontoCanada 65 works
  8. 8 University of California, San FranciscoUnited States 65 works
  9. 9 University of UtahUnited States 64 works
  10. 10 Universität HamburgGermany 61 works

Who are the leading researchers in Prostate Cancer Treatment and Research?

The most-cited researchers publishing on Prostate Cancer Treatment and Research include Ahmedin Jemal, Freddie Bray and Eric S. Lander.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Freddie Bray France 550k citations
  3. 3 Eric S. Lander United States 524k citations
  4. 4 Jacques Ferlay France 486k citations
  5. 5 George Davey Smith United Kingdom 435k citations
  6. 6 Walter Churchill Willett United States 411k citations
  7. 7 Stacey L. Gabriel United States 402k citations
  8. 8 Robert John Tibshirani United States 396k citations
  9. 9 Gad A. Getz United States 364k citations
  10. 10 Elaine R. Mardis United States 346k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Prostate Cancer Treatment and Research?

The most cited paper in Prostate Cancer Treatment and Research is "Decision Curve Analysis: A Novel Method for Evaluating Prediction Models" (Andrew Julian Vickers, Elena B. Elkin, 2006), with 6,196 citations. Next come "Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer" (5,779) and "Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer" (5,577).

Most cited papers
#PaperReleasedCitations
1 Decision Curve Analysis: A Novel Method for Evaluating Prediction Models Andrew Julian Vickers, Elena B. Elkin · Medical Decision Making Open access Nov 2006 6,196
2 Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer Ian F. Tannock, Ronald de Wit, William R. Berry et al. · New England Journal of Medicine 6 Oct 2004 5,779
3 Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer Philip W. Kantoff, Celestia S. Higano, Neal D. Shore et al. · New England Journal of Medicine Open access 28 Jul 2010 5,577
4 Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy Howard I. Scher, Karim S. Fizazi, Fred Saad et al. · New England Journal of Medicine Open access 15 Aug 2012 4,645
5 Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer Anthony Victor D'Amico · JAMA 16 Sep 1998 4,551
All 100 most cited papers, with filters and sorting

Where is Prostate Cancer Treatment and Research research done?

The largest centres of Prostate Cancer Treatment and Research research in 2022-now are New York (United States), London (United Kingdom), Shanghai (China) and Boston (United States).

Largest cities, 2022-now

  1. 1 New YorkUnited States 219 works
  2. 2 LondonUnited Kingdom 177 works
  3. 3 ShanghaiChina 158 works
  4. 4 BostonUnited States 141 works
  5. 5 BeijingChina 139 works
  6. 6 BaltimoreUnited States 120 works
  7. 7 Los AngelesUnited States 116 works
  8. 8 TokyoJapan 105 works
  9. 9 MelbourneAustralia 92 works
  10. 10 HoustonUnited States 92 works
See Prostate Cancer Treatment and Research on the map

Where is the best place to study Prostate Cancer Treatment and Research?

Among universities, judged by research, Harvard University, Cornell University and Vita-Salute San Raffaele University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 18.69%fractional works in this field (log) →share of work in the world top 10% →Vita-Salute San Raff…Università della Svi…Cornell UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 74.715.2%5.5×152 -9.8%
2Cornell UniversityUnited States 70.116.4%6.5×74 -10.1%
3Vita-Salute San Raffaele UniversityItaly 69.521.4%17.9×20 +80.2%
4Università della Svizzera italianaSwitzerland 66.921.4%15.1×11 +63.5%
5Johns Hopkins UniversityUnited States 65.315.4%5.1×68 -34.4%
6University of California, San FranciscoUnited States 64.117.3%10.5×65 -22.9%
7University of GothenburgSweden 62.323.3%4.2×17 +2.3%
8University of British ColumbiaCanada 61.314.8%4.9×51 -16.0%
9Stanford UniversityUnited States 61.323.1%2.0×26 -14.0%
10Institute of Cancer ResearchUnited Kingdom 61.318.6%65.7×18 -26.2%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Prostate Cancer Treatment and Research, country by country

Is Prostate Cancer Treatment and Research research growing?

Output in 2022-2025 was 1% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Prostate Cancer Treatment and Research.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Prostate Cancer Treatment and Research as a percentage of every work published that year, 0.040% in 2024.

still counting0.020%0.040%0.060%Prostate Cancer Treatment and Research0.042% in 202519801990200020102020

Fractional works of Prostate Cancer Treatment and Research over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Prostate Cancer Treatment and Research10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Questions people ask

Which institutions lead prostate cancer research?

By volume in 2022-now, Harvard University publishes the most Prostate Cancer Treatment and Research research, followed by Cornell University and National Institutes of Health.

Which institutions lead Prostate Cancer Treatment and Research research?
All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Prostate Cancer Treatment and Research. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.